000			01288cam a2200193 4500500
005			20260322005047.0
041			_afre
042			_adc
100	1	0	_aFrances, Pierre _eauthor
700	1	0	_aBernal, Carla _eauthor
700	1	0	_aGaubert, Robert _eauthor
700	1	0	_aManjaoui, Sami _eauthor
245	0	0	_aXylazine: The zombie drug?
260			_c2025.
500			_a64
520			_a"Tranq," or "the zombie drug," is a drug that commonly combines xylazine and fentanyl. Addiction to this drug has become a scourge in the United States, where the number of overdoses related to the drug's consumption has increased exponentially since 2018. These two substances are the cause of mainly neurological effects, including motor inertia, dysarthria, and temporal and spatial disorientation; cutaneous effects with ulcers due to tissue hypoperfusion; and cardiovascular effects, including bradycardia and hypotension, and respiratory depression. Health care professionals treating these patients must focus on withdrawal management, but also be aware of the ineffectiveness of naloxone in counteracting side effects.
786	0		_nMédecine | 21 | 1 | 2025-03-03 | p. 18-21 | 1777-2044
856	4	1	_uhttps://stm.cairn.info/revue-medecine-2025-1-page-18?lang=en&redirect-ssocas=7080
999			_c1745354 _d1745354